Rachel Spears, CCC-A in Arnold, MO - Audiologist

Rachel Spears, CCC-A is a Audiologist based in Arnold, Missouri. Rachel Spears is licensed to practice in Missouri (license number 2003005881) and her current practice location is 849 Jeffco Blvd, Arnold, Missouri. She can be reached at her office (for appointments etc.) via phone at (636) 282-5184.

NPI number for Rachel Spears is 1093294340 and her current mailing address is 849 Jeffco Blvd, Arnold, Missouri. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1093294340.

Contact Information

	Rachel Spears, CCC-A
	849 Jeffco Blvd, Arnold, MO 63010
	(636) 282-5184
	(636) 282-6980

Healthcare Provider's Profile

Full Name	Rachel Spears
Gender	Female
Speciality	Audiologist
Location	849 Jeffco Blvd, Arnold, Missouri
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1093294340
Provider Enumeration Date: 08/08/2018
Last Update Date: 08/08/2018

Medical Identifiers

Medical identifiers for Rachel Spears such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093294340	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	2003005881 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rachel Spears is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Rachel Spears, CCC-A 849 Jeffco Blvd, Arnold, MO 63010-1409 Ph: (636) 282-5184	Rachel Spears, CCC-A 849 Jeffco Blvd, Arnold, MO 63010 Ph: (636) 282-5184

News Archive

Despite vaccine, public should not get complacent about pneumococcal disease

Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.

Calif. Hospital Association sues over Medi-Cal provider cuts

The trade group for California's hospitals has sued state and federal officials to block a 10 percent cut in government reimbursements for health care providers who treat low-income patients. The California Hospital Association said in its suit, filed in federal district court in Los Angeles, that cuts to the Medi-Cal insurance program will threaten the ability of many hospitals to continue operating skilled nursing facilities.

GeoVax enters into definitive agreements to sell Series A convertible preferred stock

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

Rachel Spears, CCC-A - Audiologist in Arnold, MO